About Dylan Sammut
Dylan joined Irving Levin in October 2018 as a Research and Editorial Associate and is responsible for reporting on mergers and acquisitions in the healthcare sector. He graduated from Alfred University in May 2014 with a degree in English and Political Science. He currently lives in Bridgeport, CT with his fiancé and his overweight cat, Kimba, and in his free time he plays video games, reads, writes, and hikes on the weekends all year around.
by Dylan Sammut | Feb 8, 2021 4:15 pm | Laboratories, MRI & Dialysis
Veracyte, Inc. (NASDAQ: VCYT), the South San Francisco, California-based diagnostics company, has bought Decipher Biosciences, Inc for $600 million consisting of $250 million in cash and up to $350 million in stock. Decipher Biosciences is a commercial-stage precision... Read More »
by Dylan Sammut | Feb 8, 2021 11:30 am | Healthcare Market Updates
Even before the Covid-19 pandemic arrived in the United States early in 2020, observers expected the flow of healthcare services bankruptcies filings by small rural hospitals and other service organizations stressed by regulatory and reimbursement challenges to... Read More »
by Dylan Sammut | Feb 2, 2021 8:24 am | Physician Medical Groups, Private Equity
After Sentinel Capital Partners took a majority interest in MB2 Dental Solutions (MB2), the dental services organization became a prolific buyer in the healthcare M&A market, building a national network of practices. The organization has a presence in 24 states... Read More »
by Dylan Sammut | Feb 2, 2021 8:23 am | eHealth
MultiPlan Corporation (NYSE: MPLN), a leading value-add provider of data analytics and technology-enabled end-to-end cost management solutions to the U.S. healthcare industry, is wasting no time in expanding. If the name rings a bell, it’s because MultiPlan just went... Read More »
by Dylan Sammut | Feb 2, 2021 8:16 am | Biotechnology
Horizon Therapeutics plc (NASDAQ: HZNP) has been a major player in the healthcare M&A market for the last few years. According to search results in our Healthcare Deal Database, the company last reported a deal in April 2020, acquiring Curzion Pharmaceuticals,... Read More »